Xelpmoc Design and Tech Ltd (XELPMOC)
🎯 Key Takeaways
- Xelpmoc Design and Tech Ltd is in a turnaround phase, transitioning from early-stage development to commercialization of AI-driven platforms like DocuXray and RELY. Despite persistent losses and negative returns, the company is showing early revenue traction and strategic investments to build sustainable operations.
- Revenue declined 11.1% QoQ to ₹1 in Q1FY27.
- ⚠️ Persistent net losses and negative ROE/ROCE raise concerns about long-term viability without a clear path to profitability.
- Market Cap
- ₹127
- P/B Ratio
- 1.70
- ROE
- -10.6%
- ROCE
- -10.1%
- Debt/Equity
- 0.01
- Promoter
- 49.4%
📖 The Story
Xelpmoc Design and Tech Ltd is in a turnaround phase, transitioning from early-stage development to commercialization of AI-driven platforms like DocuXray and RELY. Despite persistent losses and negative returns, the company is showing early revenue traction and strategic investments to build sustainable operations. Management is focused on scaling commercial adoption and improving unit economics.
📰 What's Happening
In Q1 FY27, the company reported consolidated revenue of ₹9.6 crores, up 26.9% YoY from ₹7.8 crores in Q1 FY26, driven by a 22.5% YoY increase in revenue from operations to ₹9.6 crores. Adjusted Operating EBITDA improved to Rs (14.9) million from Rs (16.4) million YoY, reflecting cost discipline. Management highlighted commercial traction for its AI platform DocuXray and the launch of RELY in Agetech, with three customers onboarded. The board appointed Arvind Khandelwal as Chief Business Officer effective August 21, 2026, to strengthen business development. Additionally, the company approved an Employee Stock Option Scheme 2026 pending shareholder approval, covering up to 741,116 shares, and previously allotted 22,828 shares under the 2019 ESOP scheme, increasing paid-up capital to ₹14.82 crores.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 |
| Operating Profit | -2 | -2 | -2 | -2 | -2 |
| OPM % | -257.7% | -281.6% | -175.9% | -187.0% | -208.3% |
| Net Profit | -2 | -2 | -2 | -2 | -2 |
| EPS | ₹-1.28 | ₹-1.31 | ₹-1.36 | ₹-1.21 | ₹-1.49 |
Revenue has shown sequential and YoY improvement, rising from ₹7.8 crores in Q1 FY26 to ₹9.6 crores in Q1 FY27, indicating early commercial validation of its AI platforms. However, profitability remains negative, with operating losses persisting across quarters and net losses continuing. The improvement in adjusted EBITDA suggests incremental cost control, but the company is still in the investment phase. Management attributes this progress to portfolio investments and commercial launches, signaling a shift from development to revenue generation, though scalability and margin improvement remain key challenges.
🔮 Management Outlook & What's Next
Management expressed confidence in growth through proprietary AI platforms and plans to deepen client relationships and expand market reach. They highlighted the commercial launch of the RELY senior care platform and continued investment in DocuXray as catalysts for future revenue expansion. Forward-looking statements in the filing noted risks related to market and technological changes but underscored strategic focus on scaling AI-driven solutions. No specific financial targets or timelines for profitability were disclosed, but the narrative centers on commercialization as the path forward.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 |
| Reserves | 49 | 49 | 60 | 62 |
| Borrowings | 0 | 1 | 1 | 0 |
| Total Liabilities | 72 | 72 | 86 | 86 |
| Fixed Assets | 1 | 1 | 1 | 0 |
| Investments | 66 | 63 | 78 | 79 |
| Total Assets | 72 | 72 | 86 | 86 |
The balance sheet shows stable equity of ₹15 crores and growing reserves to ₹62 crores as of March 2026, indicating retained earnings reinvestment rather than capital infusion. Borrowings remain minimal at ₹1 crore, suggesting no active debt financing for operations. Total assets have increased from ₹72 crores to ₹86 crores, reflecting asset accumulation likely from investments in portfolio companies and platform development. The company is funding growth internally through equity reserves and minimal debt, with no major capital raises observed recently.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -5 |
| Investing | +6 |
| Financing | -2 |
| Net Cash Flow | +0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 51.4% | 49.7% | 49.5% | 49.4% |
| FII | 0.0% | 0.0% | 0.1% | 0.1% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 43.3% | 45.2% | 45.0% | 45.2% |
| # Shareholders | 12,601 | 11,984 | 11,590 | 11,635 |
Promoter holding has declined from 51.38% in Q2 FY26 to 49.39% in Q1 FY27, indicating gradual dilution or stake sales, though still above the 50% threshold. FII holding remains negligible at 0.07%, while DII remains at 0%. Public shareholding has increased slightly from 43.3% to 45.19%, with the number of shareholders rising to 11,635, suggesting retail interest. No significant institutional accumulation is evident, but the stable promoter stake and growing retail base may support liquidity.
⚖️ Peer Comparison — IT - Software
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| TCS | 7.37 L Cr | 14.8 | 63.2% | — | 0.00 |
| INFY | 4.08 L Cr | 13.6 | 44.9% | — | 0.00 |
| HCLTECH | 3.32 L Cr | 19.0 | 31.6% | — | 0.00 |
| WIPRO | 1.55 L Cr | 12.4 | 18.1% | — | 0.19 |
| TECHM | 1.49 L Cr | 26.2 | 24.8% | — | 0.00 |
| LTM | 1.19 L Cr | 22.7 | 30.5% | — | 0.00 |
| OFSS | 90,555 | 26.5 | 60.3% | — | 0.00 |
| PERSISTENT | 82,117 | 42.3 | 32.7% | — | 0.00 |
| COFORGE | 76,187 | 35.0 | 25.6% | — | 0.04 |
| MPHASIS | 41,765 | 21.8 | 22.3% | — | 0.17 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Persistent net losses and negative ROE/ROCE raise concerns about long-term viability without a clear path to profitability. 2. Heavy reliance on AI platform commercialization introduces execution and market adoption risks, especially in competitive and evolving tech segments. 3. Minimal institutional interest and low float could lead to high volatility. 4. ESOP dilution risk remains if the 2026 scheme gains approval, potentially pressuring share price if not managed carefully.
📋 Recent Filings
- 🔴 Announcement2026-09-22Xelpmoc Design and Tech announced the grant of 145,000 employee stock options under its 2020 scheme, with a Rs.10 exercise price and three-year vestin…
- 🔴 Corporate Action2026-09-18Xelpmoc Design and Tech announced the allotment of 8,400 equity shares under its 2019 Employee Stock Option Scheme, exercised at Rs.10 per share, gene…
- 🟡 Board Meeting2026-09-11Xelpmoc Design and Tech announced the sale of its entire stake in Woovly India Private Limited for Rs.14.58 crores, approved by its Audit Committee an…
- 🔴 annual report2026-09-07Xelpmoc Design and Tech Limited reported FY2026 revenue of **₹37,353.38 crores**, down from **₹39,011.88 crores** in FY2025, with India contributing *…
- 🔴 annual report2026-09-07Xelpmoc Design and Tech Limited reported FY2026 revenue of **₹37,353.38 crores**, down from **₹39,011.88 crores** in FY2025, with foreign currency ear…
- 🔴 Financial Results2026-08-14Xelpmoc Design and Tech Limited reported consolidated revenue of **₹9.6 crores** for Q1 FY27, down from **₹10.8 crores** in Q4 FY26 but up from **₹7.8…
- 🔴 Financial Results2026-08-14Xelpmoc Design And Tech Limited announced its Q1 FY2026 financial results and key governance updates on August 14, 2026. The company approved unaudite…
- 🔴 Announcement2026-08-14Xelpmoc Design And Tech Limited announced on August 14, 2026 that its Nomination and Remuneration Committee approved the grant of 1,20,000 employee st…
- 🔴 Financial Results2026-08-14Xelpmoc Design and Tech Limited reported consolidated revenue of Rs 11.7 million for Q1 FY27, down 6.8% QoQ but up 26.9% YoY, driven by a 22.5% YoY in…
- 🔴 Financial Results2026-08-14Xelpmoc Design And Tech Limited announced its Q1 FY2026 financial results and board-level appointments on August 14, 2026. The filing disclosed unaudi…
🧠 Analyst's Read
Xelpmoc is in an early commercialization phase with modest revenue growth and improving cost metrics, but profitability remains distant. Investors should monitor execution of the RELY and DocuXray launches, progress toward margin improvement, and any dilution from the ESOP scheme. The next few quarters will be critical in validating management’s commercialization strategy and scaling potential.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when XELPMOC files new disclosures
Track XELPMOC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track XELPMOC — FreeFree account · 2 AI queries/day